Gulyban Akos

Service(s) : Physique médicale , Radiothérapie

Akos.Gulyban [at] bordet.be

Publications

Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis.

Auteurs : Kedves A, Gulyban A, Glavak C, Toller G, Völgyi Z, Faour A, Bálint A, Petrási B, Rák T, Lakosi F
Année : 2022
Journal : Acta Oncol

Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values.

Auteurs : Paquier Z, Chao SL, Acquisto A, Fenton C, Guiot T, Dhont J, Levillain H, Gulyban A, Bali MA, Reynaert N
Année : 2022
Journal : Biomed Phys Eng Express

Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG

Auteurs : Dragan T, Van Gossum A, Duprez F, Lalami Y, Lefebvre Y, Mootassim-Billah S, Beauvois S, Gulyban A, Vandekerkhove C, Boegner P, Paesmans M, Ameye L, Digonnet A, Quiriny M, Dequanter D, Lipski S, Willemse E, Rodriguez A, Carlot S, Karaca Y, Lemort M, Emonts P, Al Wardi C, Van Gestel D
Année : 2022
Journal : Trials

Triggered Imaging With Auto Beam Hold and Pre-/Posttreatment CBCT During Prostate SABR: Analysis of Time Efficiency, Target Coverage, and Normal Volume Changes.

Auteurs : Kisivan K, Antal G, Gulyban A, Glavak C, Laszlo Z, Kalincsak J, Gugyeras D, Jenei T, Csima M, Lakosi F
Année : 2021
Journal : Pract Radiat Oncol

HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study.

Auteurs : Lakosi F, Antal G, Pall J, Farkas A, Jenei T, Nagy D, Liptak J, Sipocz I, Pytel A, Csima M, Gulyban A, Toller G
Année : 2021
Journal : Brachytherapy

Plus de publications »

Gulyban Akos

Languages

Contact